Skip to content

Clinical trials

Phase 2/3 Liver Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Diseases Phase: Phase 2/3 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20073
20082
20131
20141
20161
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status3
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radboud University Medical Center2
Eastern Hepatobiliary Surgery Hospital1
Mayo Clinic1
Northwestern University1
Shanghai Zhongshan Hospital1
UMC Utrecht1
University Hospital, Geneva1
University of Alberta1
University of Michigan1
University of Texas Southwestern Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Diseases11
Hepatomegaly3
Digestive System Neoplasms2
Polycystic Kidney Diseases2
Polycystic Kidney, Autosomal Dominant2
Abdominal Pain1
Adenocarcinoma1
Carcinoma, Hepatocellular1
Chickenpox1
Colorectal Neoplasms1

Trials

Showing 76 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.